The Refill Cadence Problem: Syncing 28-Day Supplies With 30-Day Months

GLP-1 Prescriptions Editorial Team · July 17, 2026 · 8 min read
Affiliate Disclosure: This site contains affiliate links to telehealth providers. If you click a link and make a purchase, we may receive a commission at no extra cost to you. All opinions are our own. Links marked "Paid link" are sponsored placements. See our full disclosure.

The Math Problem Nobody Warned You About

Here's a frustration that virtually every GLP-1 patient encounters: your medication is dosed weekly (4 injections per fill = 28-day supply), but your insurance plan allows refills every 30 days. By month three, you're running out of medication two days before your plan allows a refill. By month six, you've accumulated enough gap days to miss a full dose.

This isn't a GLP-1-specific problem — it affects any weekly medication on a 30-day refill cycle. But for GLP-1 patients, missing even one weekly dose during titration can cause side effects when you restart, and during maintenance, a gap means temporarily losing the appetite suppression you depend on.

Solutions That Actually Work

Ask for a 28-day supply override. Your prescriber can write the prescription for a 28-day supply and request that your plan allow refills on a 28-day cycle instead of 30. Some plans accommodate this; others don't.

Fill a few days early. Most insurance plans allow refills when 75-80% of the supply has been used. For a 28-day supply, that's around day 21-22. Filing consistently at the earliest allowed date builds a small buffer over time.

Coordinate with your pharmacy. Your pharmacist can set up auto-refill at the earliest allowed date, ensuring you never wait longer than necessary. They can also track your fill history and flag potential gap days before they happen.

90-day supply (if available). A 90-day fill through mail-order pharmacy often alleviates the monthly timing issue entirely. You receive 12-13 weeks of medication at once, and the next fill cycle is far enough out that the 28/30 discrepancy is absorbed.

Editor's Choice

Embody

Top Pick — $400 CPA

From $249/mo

Injectable semaglutide only. Compounded — not FDA-approved.

Check Eligibility →

What to Do When You Actually Run Out

If you hit a gap day and your pharmacy can't fill yet, options include: requesting an override from your insurance company (call member services and explain the 28/30 discrepancy), asking your prescriber to call the pharmacy with an override authorization, or using a manufacturer savings program for a bridge fill at a different pharmacy.

For compounded GLP-1 patients on telehealth platforms with monthly shipping, this problem is less common because the platform typically ships on a fixed monthly schedule rather than using insurance refill windows. However, shipping delays can create their own gaps — always have at least one extra dose on hand if possible.

Building a Refill Calendar

The simplest prevention: build a calendar. Mark your injection days, your fill dates, your earliest-allowed-refill dates, and your travel dates. When you see a gap forming, act early — request the refill, coordinate with your pharmacy, or contact your prescriber for an override.

Many patients use phone calendar reminders or medication tracking apps to automate this. The key insight is that the 28/30 mismatch is predictable — it happens every month, and it accumulates over time. Planning for it eliminates the last-minute scramble.

Data-Driven

Wellorithm

Science-Forward

From $199/mo

Compounded — not FDA-approved.

Check Eligibility →
⭐ Editor's Pick

Sunlight

Editor's Pick June 2026

From $149/mo

Compounded — not FDA-approved.

Check Eligibility →
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications with potential side effects including nausea, vomiting, diarrhea, and in rare cases, pancreatitis or thyroid tumors. Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Always consult a licensed healthcare provider before starting any medication. Compounded medications are not FDA-approved for safety, efficacy, or quality.